Listed

Citius Oncology, Inc.: Form 10-Q for the period ended Sep 30, 2022

Filed with the SEC on Nov 28, 2022 and accepted by EDGAR at Nov 28, 2022, 16:55 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Basic EPS3 months2022-07-01 to 2022-09-30$0.00us-gaap:EarningsPerShareBasic
Basic EPS9 months2022-01-01 to 2022-09-30$0.00us-gaap:EarningsPerShareBasic
Total assetsAt period end2022-09-30$256.7kus-gaap:Assets
Current liabilitiesAt period end2022-09-30$266.9kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2022-09-30−$10.1kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-22-033847. Last ingested by Listed: Nov 14, 2026, 21:33 ET. Listed shows no prices and gives no investment advice.